Cargando…

Development of gut mycobiome in infants and young children: a prospective cohort study

BACKGROUND: The composition of the gut fungal microbiome, mycobiome, is likely associated with human health. Yet, the development of gut mycobiome is poorly understood in infants and children. Here we investigate how perinatal events influence the development of gut mycobiome. METHODS: In this prosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Turunen, Jenni, Paalanne, Niko, Reunanen, Justus, Tapiainen, Terhi, Tejesvi, Mysore V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382308/
https://www.ncbi.nlm.nih.gov/pubmed/36670159
http://dx.doi.org/10.1038/s41390-023-02471-y
_version_ 1785080651632869376
author Turunen, Jenni
Paalanne, Niko
Reunanen, Justus
Tapiainen, Terhi
Tejesvi, Mysore V.
author_facet Turunen, Jenni
Paalanne, Niko
Reunanen, Justus
Tapiainen, Terhi
Tejesvi, Mysore V.
author_sort Turunen, Jenni
collection PubMed
description BACKGROUND: The composition of the gut fungal microbiome, mycobiome, is likely associated with human health. Yet, the development of gut mycobiome is poorly understood in infants and children. Here we investigate how perinatal events influence the development of gut mycobiome. METHODS: In this prospective cohort study of 140 infants, we used ITS gene sequencing of fecal samples from birth to the age of 18 months. We compared gut mycobiome composition according to delivery mode and exposure to intrapartum antibiotics during vaginal delivery. RESULTS: At birth, gut mycobiome were dominated by the genus Candida, at 6-month stool samples by Malassezia and Cystofilobasidium, and the 18-month stool samples by Trichosporon and unidentified fungi. Perinatal factors altered mycobiome. At 18 months, gut mycobiome of infants born vaginally consisted mostly of Trichosporon (32%) and unidentified fungi (31%), while those born via Cesarean section delivery samples had mycobiome dominated by Saccharomyces (50%). At the age of 18 months, those exposed to intrapartum antibiotics had mycobiome dominated by Trichosporon (66%) not seen in those unexposed to antibiotics. CONCLUSIONS: Delivery mode and exposure to intrapartum antibiotic prophylaxis were markedly associated with gut mycobiome composition from birth to 18 months of age. IMPACT: The composition of the gut mycobiome is likely associated with human health. Yet, the development of gut mycobiome is poorly understood in infants and children. In this prospective cohort study, delivery mode and exposure to intrapartum antibiotic prophylaxis were markedly associated with gut mycobiome composition from birth to 18 months of age. The impact of intrapartum antibiotic prophylaxis on fungal microbiome in vaginally born infants, previously shown to influence gut bacteriome composition, may be explained by the interaction between bacteria and fungi. Gut mycobiome composition likely deserves further investigation in relation to gut microbiome and health in children.
format Online
Article
Text
id pubmed-10382308
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group US
record_format MEDLINE/PubMed
spelling pubmed-103823082023-07-30 Development of gut mycobiome in infants and young children: a prospective cohort study Turunen, Jenni Paalanne, Niko Reunanen, Justus Tapiainen, Terhi Tejesvi, Mysore V. Pediatr Res Basic Science Article BACKGROUND: The composition of the gut fungal microbiome, mycobiome, is likely associated with human health. Yet, the development of gut mycobiome is poorly understood in infants and children. Here we investigate how perinatal events influence the development of gut mycobiome. METHODS: In this prospective cohort study of 140 infants, we used ITS gene sequencing of fecal samples from birth to the age of 18 months. We compared gut mycobiome composition according to delivery mode and exposure to intrapartum antibiotics during vaginal delivery. RESULTS: At birth, gut mycobiome were dominated by the genus Candida, at 6-month stool samples by Malassezia and Cystofilobasidium, and the 18-month stool samples by Trichosporon and unidentified fungi. Perinatal factors altered mycobiome. At 18 months, gut mycobiome of infants born vaginally consisted mostly of Trichosporon (32%) and unidentified fungi (31%), while those born via Cesarean section delivery samples had mycobiome dominated by Saccharomyces (50%). At the age of 18 months, those exposed to intrapartum antibiotics had mycobiome dominated by Trichosporon (66%) not seen in those unexposed to antibiotics. CONCLUSIONS: Delivery mode and exposure to intrapartum antibiotic prophylaxis were markedly associated with gut mycobiome composition from birth to 18 months of age. IMPACT: The composition of the gut mycobiome is likely associated with human health. Yet, the development of gut mycobiome is poorly understood in infants and children. In this prospective cohort study, delivery mode and exposure to intrapartum antibiotic prophylaxis were markedly associated with gut mycobiome composition from birth to 18 months of age. The impact of intrapartum antibiotic prophylaxis on fungal microbiome in vaginally born infants, previously shown to influence gut bacteriome composition, may be explained by the interaction between bacteria and fungi. Gut mycobiome composition likely deserves further investigation in relation to gut microbiome and health in children. Nature Publishing Group US 2023-01-20 2023 /pmc/articles/PMC10382308/ /pubmed/36670159 http://dx.doi.org/10.1038/s41390-023-02471-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Basic Science Article
Turunen, Jenni
Paalanne, Niko
Reunanen, Justus
Tapiainen, Terhi
Tejesvi, Mysore V.
Development of gut mycobiome in infants and young children: a prospective cohort study
title Development of gut mycobiome in infants and young children: a prospective cohort study
title_full Development of gut mycobiome in infants and young children: a prospective cohort study
title_fullStr Development of gut mycobiome in infants and young children: a prospective cohort study
title_full_unstemmed Development of gut mycobiome in infants and young children: a prospective cohort study
title_short Development of gut mycobiome in infants and young children: a prospective cohort study
title_sort development of gut mycobiome in infants and young children: a prospective cohort study
topic Basic Science Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382308/
https://www.ncbi.nlm.nih.gov/pubmed/36670159
http://dx.doi.org/10.1038/s41390-023-02471-y
work_keys_str_mv AT turunenjenni developmentofgutmycobiomeininfantsandyoungchildrenaprospectivecohortstudy
AT paalanneniko developmentofgutmycobiomeininfantsandyoungchildrenaprospectivecohortstudy
AT reunanenjustus developmentofgutmycobiomeininfantsandyoungchildrenaprospectivecohortstudy
AT tapiainenterhi developmentofgutmycobiomeininfantsandyoungchildrenaprospectivecohortstudy
AT tejesvimysorev developmentofgutmycobiomeininfantsandyoungchildrenaprospectivecohortstudy